AQR Capital Management »

Takeda Pharmaceutical shares owned by AQR Capital Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.1M 147k 14.22
2024-06-30 $1.2M 90k 12.94
2024-03-31 $493k 36k 13.89

More positions owned by AQR Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ge Aerospace Com New (GE)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Zoom Video Communications In Cl A (ZM)
Cigna Corp (CI)
At&t (T)
Progressive Corporation (PGR)
Alphabet Cap Stk Cl C (GOOG)

View all positions for AQR Capital Management

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Mondrian Investment Partners
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Renaissance Technologies
First Trust Advisors
Brandes Investment Partners
Van Eck Associates Corp.
BlackRock
Citadel Advisors
Northern Trust
Managed Asset Portfolios
Envestnet Asset Management
BlackRock

View all funds holding Takeda Pharmaceutical